Somatostatin receptor-2 negatively regulates β-adrenergic receptor mediated Ca(2+) dependent signaling pathways in

Rishi K Somvanshi1, Shenglong Zou1, Xiaofan Qiu1

  • 1Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC V6T1Z3, Canada.

Insights

Somatostatin receptor 2 (SSTR2) protects the heart by regulating calcium signaling pathways. This receptor modulates beta-adrenergic receptor (β-AR) activity, preventing cardiac hypertrophy and complications.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pharmacology

Background:

  • Beta-adrenergic receptors (β-ARs) mediate cardiac function but their overactivation can lead to hypertrophy.
  • Intracellular calcium (Ca2+) signaling is critical in cardiac function and hypertrophy.
  • Somatostatin receptor 2 (SSTR2) role in cardiac signaling is not fully understood.

Purpose of the Study:

  • To investigate the role of SSTR2 in modulating β-AR signaling pathways.
  • To determine if SSTR2 activation impacts Ca2+ handling and cardiac hypertrophy.

Main Methods:

  • Utilized H9c2 cells to study receptor interactions and signaling.
  • Administered SSTR2 selective agonists and β-AR agonists (isoproterenol, formoterol).
  • Assessed cAMP formation, protein kinase A (PKA) phosphorylation, protein kinase C (PKC) expression, calcineurin activity, NFAT translocation, and cellular hypertrophy markers.

Main Results:

  • SSTR2 colocalizes with β1AR and β2AR in H9c2 cells.
  • SSTR2 activation inhibited isoproterenol/formoterol-induced cAMP production, PKA phosphorylation, and PKC expression.
  • SSTR2 activation suppressed calcineurin/NFAT signaling and prevented isoproterenol-induced cardiac hypertrophy.

Conclusions:

  • SSTR2 plays a significant role in modulating β-AR mediated signaling pathways.
  • SSTR2 activation demonstrates a protective effect against cardiac hypertrophy by regulating Ca2+ signaling.
  • SSTR2 represents a potential therapeutic target for managing cardiac hypertrophy.

Related Concept Videos

Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.0K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K